What is Leerink Partnrs’ Forecast for ZNTL Q3 Earnings?
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) – Leerink Partnrs issued their Q3 2025 earnings estimates for Zentalis Pharmaceuticals in a report issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens forecasts that the company will post earnings of ($0.41) per share for the quarter. The consensus estimate for Zentalis Pharmaceuticals’ current full-year earnings […]
![What is Leerink Partnrs’ Forecast for ZNTL Q3 Earnings?](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/zentalis-pharmaceuticals-inc-logo-1200x675.png?v=20240509152328&w=240&h=240&zc=2)